Emeryville, CA, United States of America

Brooks Boyd

USPTO Granted Patents = 4 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 2017-2022

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Inventor Brooks Boyd

Introduction

Brooks Boyd is an accomplished inventor based in Emeryville, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. With a total of four patents to his name, Boyd's work focuses on enhancing the efficacy and safety of injectable medications.

Latest Patents

One of Brooks Boyd's latest patents involves compositions and methods that utilize a polymer, solvent, and high viscosity liquid carrier material. This innovative formulation may include a pharmaceutical active agent, a high viscosity liquid carrier material (HVLCM), a lactic acid-based polymer, and an organic solvent. The patent describes a carrier formulation designed for the controlled release of injectable drugs. The formulation may consist of a non-water soluble high viscosity liquid, such as sucrose acetate isobutyrate, along with a lactic-acid based polymer, which may be a poly(lactic acid)(glycolic acid), and an organic solvent that maintains the composition in a monophasic form at 25°C in one atmosphere. The drug in this formulation is released in a controlled manner, with less than 10% of the drug released in the first five hours, followed by a gradual release over a period of 28 days. This innovative approach is particularly beneficial for delivering anti-schizophrenia agents via injection.

Career Highlights

Brooks Boyd is currently employed at Durect Corporation, where he continues to advance his research and development efforts. His work has been instrumental in creating formulations that improve patient outcomes and enhance the therapeutic effects of medications.

Collaborations

Some of his notable coworkers include Jeremy C Wright and Wilma Tamraz, who contribute to the collaborative environment at Durect Corporation.

Conclusion

Brooks Boyd's innovative contributions to pharmaceutical formulations demonstrate his commitment to improving drug delivery systems. His patents reflect a deep understanding of the complexities involved in medication administration and the potential for enhanced patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…